Herantis pharma Stock: price and insider trades · Sweden
Herantis pharma: what insiders have been doing
Every trade that managers of Herantis pharma disclose to Finansinspektionen is tracked on this page. The past year has been quiet: not a single insider filing for Herantis pharma. The previous disclosure was published on 2 October 2020.
Looking back to 2020, when coverage begins, insiders filed no purchases and 3 sales.
Elsewhere in the same market, our signals recently picked up insider purchases at Dynavox Group AB and Rusta AB (publ). Source: insider filings from Finansinspektionen. Past trades are no guide to future returns.
Financial data
· cache
- 1,528 shares@ SEK 72.523814.6% of flowAktieISIN FI4000087861FI:csv-dabda56d5b42b61da5f2
- 3,888 shares@ SEK 71.978836.8% of flowAktieISIN FI4000087861FI:csv-bfc916c3348c8c45d4db
- 4,584 shares@ SEK 80.071548.6% of flowAktieISIN FI4000087861FI:csv-1221ecf64a3677ebacfd
3 of 3 declarations
About Herantis pharma
Herantis Pharma is a biopharmaceutical company focused on developing innovative treatments for neurodegenerative diseases. It is listed on the Stockholm Stock Exchange.
Recent ranked signals on the same market
Purchases our model currently ranks for the recommendations list.
All recommendations